The Journal of Infectious Diseases · 2018 · 76 citations · 27 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceInnate ImmunityMedical MicrobiologyAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceAntimicrobial TherapyCombination Antimicrobial TherapyBacteriophage TherapyComplement System ActivationComplement-mediated Bacterial KillingComplement-mediated Cell LysisPseudomonas Aeruginosa Infection TreatmentPseudomonas Aeruginosa ResistanceRespiratory Bacterial Infections TreatmentTreatment Of Bacterial Resistance
Emergence of multidrug-resistant (MDR) bacterial infections is a major problem in clinical medicine. Development of new strategies such as phage therapy may be a novel approach for treatment of life-threatening infections caused by MDR bacteria. A newly isolated phage, MMI-Ps1, with strong lytic activity was used for treatment of acute lung infection with Pseudomonas aeruginosa in a mouse model. Intranasal administration of a single dose of MMI-Ps1 immediately after infection provided a significant level of protection and increased the survival duration. Moreover, treatment of infected mice with phage as late as 12 hours after infection was still protective. Our in vitro results are the first to show the synergistic elimination of serum-resistant Pseudomonas strains by phage and complement. Phage therapy increases the efficacy of complement-mediated lysis of serum-resistant P. aeruginosa strains, indicating the importance of an intact complement system in clearing Pseudomonas infection during phage therapy.
27
A. Wright, Catherine Hawkins, Erik Änggård et al. · Clinical Otolaryngology · 2009 · 837 citations · Full text
Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa
Benjamin K. Chan, Mark Sistrom, John E. Wertz et al. · Scientific Reports · 2016 · 722 citations · Full text